Compare Schlumberger NV (SLB) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Schlumberger NV vs Summit Therapeutics Inc — how do they compare? Schlumberger NV trades at $46.6 (market cap $69.36B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Schlumberger NV is far larger — about 6.6× Summit Therapeutics Inc's market cap, and Schlumberger NV pays a 2.54% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SLB | SMMT | |
|---|---|---|
Market Cap | $69.36B | $10.48B |
Sector | Energy | Health |
52-Week High | $58.01 | $29.32 |
52-Week Low | $31.72 | $13.05 |
Enterprise Value | $77.58B | $9.90B |
Dividend Yield | 2.54% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
